Save 60% Off all remaining inventory with Promo Code: ICE

FDA Finally Approves First CBD-Based Medicine for Epilepsy

June 26, 2018

TESTSTSARDSAR

FDA Finally Approves First CBD-Based Medicine for Epilepsy by Patricia Miller

In a historic decision, the US Food and Drug Administration has approved the first-ever cannabis-derived medication. Epidiolex, a CBD-based oral solution, has been approved to treat patients two years and older who are suffering from Dravet syndrome and Lennox-Gastaut syndrome, two severe forms of epilepsy. The approval sets a new precedence for CBD-based prescription drugs, signaling an end to the prohibitions which have prevented research and development of cannabis-derived medications.

In their press release, the FDA credits the drug’s approval to “adequate and well-controlled clinical studies” enacted during the research phase of its development. Researchers conducted three randomized, double-blind, placebo-controlled clinical trials with 516 patients who were afflicted with either Dravet syndrome or Lennox-Gastaut syndrome. According to the FDA’s report, “Epidiolex, taken along with other medications, was shown to be effective in reducing the frequency of seizures when compared with placebo.” The long battle to obtain FDA approval for CBD-based epilepsy treatments has been building nationwide, finally culminating in this life-changing announcement.

People afflicted with epileptic seizures have been migrating to Colorado, California, and other adult-use states for years, seeking to use CBD oil as an alternative to traditional treatments, or sometimes pursuing it as their last hope to treat a disease with no known cure. Today’s announcement will change the lives of those currently using CBD to treat their epilepsy, and will allow thousands of families across the country to begin a CBD-based drug regimen. Doctors can now prescribe the medication, confidently provide dosing information, and create long-term treatment plans— any of which was impossible prior to today’s proclamation.

According to Barbara Carreno, Drug Enforcement Agency press officer, the decision could have long-term implications for the scheduling classification of CBDs. In an interview with Ben Adlin of Leafly, Carreno affirmed, “If they [the FDA] … announce that they’re approving Epidiolex, absolutely we’ll go into a different schedule. There’s no ifs, ands, or buts about it.” The classification of CBD as a Schedule I drug prevents the scientific community from properly researching the substance and prohibits its sale or consumption in most states (unless the CBD can be reliably traced as having originated from a Cannabis sativa plant with less than .3 percent THC content). Rescheduling would have significant implications for the hemp and cannabis industries as a whole.

Though the approval of Epidiolex is just the beginning for cannabis-based medicine, it’s an encouraging step forward in what is often a slow-moving regulatory battle. Individuals affected by epilepsy as well as proponents of CBD-based therapies are likely to rejoice at this announcement, one that may herald a new era of cannabis-based drug research and development.

A link to your site, with your site's name and description as anchor text.





Also in Education

Owning Guns is a Constitutional Right, Unless You’re a Cannabis User

September 28, 2022

Take two of the most hot-button, tendentious issues of our time – cannabis use and gun rights – combine them, and now we really have a debate. As the law currently stands, medical cannabis patients are not afforded their 2nd amendment right to bear arms. Technically, all cannabis consumers are banned from buying guns, but only medical […]

The post Owning Guns is a Constitutional Right, Unless You’re a Cannabis User appeared first on Cannadelics.

Continue Reading

Cannabis policy changes in Africa are welcome. But small producers are the losers

September 28, 2022

TESTSTSARDSAR

Cannabis policy changes in Africa are welcome. But small producers are the losers by Clemence Rusenga

Cannabis is a drug crop with a long history in Africa. Alongside coca and opium poppy, it has been subjected to international control for nearly a century. The International Opium Convention of 1925 institutionalised the international control system and extended the scope of control to cannabis. In 1961 a new international convention was adopted to […]

A link to your site, with your site's name and description as anchor text.

Continue Reading

University of Sydney to Offer Free Cannabis Testing

September 27, 2022

TESTSTSARDSAR

University of Sydney to Offer Free Cannabis Testing by Johnny Green

The University of Sydney is launching a fairly robust study in an attempt to, as the university describes it, “investigate cannabis consumption, behaviours, and attitudes among users.” Part of the study involves offering free, anonymous cannabis testing for people that cultivate their own cannabis in the Australian Capital Territory (ACT). Cannabis was decriminalized in 2020 in the […]

A link to your site, with your site's name and description as anchor text.

Continue Reading

Inventory Clearance Sale

Save 60% Off all remaining inventory with Promo Code: ICE